Answers are grounded in this paper and cite their sources.
Experimental analysis reveals that Notoginsenoside R1 alleviates intervertebral disc degeneration by targeting ferroptosis and autophagy mechanisms.
, and ROS levels. NGR1 also promoted autophagy, as indicated by increased Beclin-1 and LC3 II/I levels in NP tissues. Moreover, serum IL-1β and IL-6 were reduced by NGR1 in IDD rats. NGR1 significantly reduced the levels of predicted targets STAT3, IL1B, and MAPK3. In erastin-induced NP cells, NGR1 significantly restored cell viability, enhanced autophagy, and suppressed ferroptosis as well as STAT3, IL1B, and MAPK3 expression, all of which were partially reversed by 3-MA or colivelin.4. NGR1 alleviates IDD by inhibiting ferroptosis and promoting autophagy, potentially via STAT3 signaling, thereby preserving disc integrity and delaying disease progression.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: